Pharmacological Characterization of [18F]-FNM and Evaluation of NMDA Receptors Activation in a Rat Brain Injury Model - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Molecular Imaging and Biology Année : 2023

Pharmacological Characterization of [18F]-FNM and Evaluation of NMDA Receptors Activation in a Rat Brain Injury Model

Résumé

Purpose NMDA receptors (NMDARs) dysfunction plays a central role in the physiopathology of psychiatric and neurodegenerative disorders whose mechanisms are still poorly understood. The development of a PET (positron emission tomography) tracer able to selectively bind to the NMDARs intra-channel PCP site may make it possible to visualize NMDARs in an open and active state. We describe the in vitro pharmacological characterization of [ 18 F]-fluoroethylnormemantine ([ 18 F]-FNM) and evaluate its ability to localize activated NMDA receptors in a rat preclinical model of excitotoxicity. Procedures The affinity of the non-radioactive analog for the intra-channel PCP site was determined in a radioligand competition assay using [ 3 H]TCP ([ 3 H]N-(1-[thienyl]cyclohexyl)piperidine) on rat brain homogenates. Selectivity was also investigated by the displacement of specific radioligands targeting various cerebral receptors. In vivo brain lesions were performed using stereotaxic quinolinic acid (QA) injections in the left motor area (M1) of seven Sprague Dawley rats. Each rat was imaged with a microPET/CT camera, 40 min after receiving a dose of 30 MBq + / − 20 of [ 18 F]-FNM, 24 and 72 h after injury. Nine non-injured rats were also imaged using the same protocol. Results FNM displayed IC 50 value of 13.0 ± 8.9 µM in rat forebrain homogenates but also showed significant bindings on opioid receptors. In the frontal and left somatosensory areas, [ 18 F]FNM PET detected a mean of 37% and 41% increase in [ 18 F]FNM uptake (p < 0,0001) 24 and 72 h after QA stereotaxic injection, respectively, compared to the control group. Conclusions In spite of FNM's poor affinity for NMDAR PCP site, this study supports the ability of this tracer to track massive activation of NMDARs in neurological diseases.
Fichier principal
Vignette du fichier
Beaurain et al 2023.pdf (4.63 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-04244094 , version 1 (16-10-2023)

Identifiants

Citer

Marie Beaurain, Franck Talmont, Damien Pierre, Patrice Péran, Samuel Boucher, et al.. Pharmacological Characterization of [18F]-FNM and Evaluation of NMDA Receptors Activation in a Rat Brain Injury Model. Molecular Imaging and Biology, 2023, 25 (4), pp.692 - 703. ⟨10.1007/s11307-023-01811-y⟩. ⟨hal-04244094⟩
29 Consultations
8 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More